Literature DB >> 11447203

Concurrent upregulation of urokinase plasminogen activator receptor and CD11b during tuberculosis and experimental endotoxemia.

N P Juffermans1, P E Dekkers, A Verbon, P Speelman, S J van Deventer, T van der Poll.   

Abstract

Patients with tuberculosis had higher expression of monocyte urokinase receptor (uPAR) and CD11b than controls. In vitro, lipoarabinomannan and lipopolysaccharide (LPS) from Escherichia coli shared the ability to enhance uPAR and CD11b expression on monocytes and granulocytes. In healthy volunteers, LPS induced increases in monocyte and granulocyte uPAR and CD11b.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447203      PMCID: PMC98617          DOI: 10.1128/IAI.69.8.5182-5185.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

Review 1.  uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways?

Authors:  F Blasi
Journal:  Immunol Today       Date:  1997-09

2.  Nonopsonic and opsonic association of Mycobacterium tuberculosis with resident alveolar macrophages is inefficient.

Authors:  R W Stokes; L M Thorson; D P Speert
Journal:  J Immunol       Date:  1998-06-01       Impact factor: 5.422

3.  Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells.

Authors:  D I Simon; N K Rao; H Xu; Y Wei; O Majdic; E Ronne; L Kobzik; H A Chapman
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

4.  The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes.

Authors:  R G Sitrin; R F Todd; E Albrecht; M R Gyetko
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

5.  Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium.

Authors:  L S Schlesinger; M A Horwitz
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

6.  Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia.

Authors:  P E Dekkers; T ten Hove; A A te Velde; S J van Deventer; T van Der Poll
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

7.  Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan.

Authors:  N P Juffermans; A Verbon; S J van Deventer; H van Deutekom; J T Belisle; M E Ellis; P Speelman; T van der Poll
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

8.  Increased production of hydrogen peroxide and expression of CD11b/CD18 on alveolar macrophages in patients with active pulmonary tuberculosis.

Authors:  H P Kuo; T C Ho; C H Wang; C T Yu; H C Lin
Journal:  Tuber Lung Dis       Date:  1996-10

9.  Function of the urokinase receptor (CD87) in neutrophil chemotaxis.

Authors:  M R Gyetko; R G Sitrin; J A Fuller; R F Todd; H Petty; T J Standiford
Journal:  J Leukoc Biol       Date:  1995-11       Impact factor: 4.962

10.  Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.

Authors:  A E May; S M Kanse; L R Lund; R H Gisler; B A Imhof; K T Preissner
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

View more
  7 in total

1.  Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late-onset Sepsis.

Authors:  Emel Okulu; Saadet Arsan; Ilke Mungan Akin; Can Ates; Serdar Alan; Atila Kilic; Begum Atasay
Journal:  J Clin Lab Anal       Date:  2014-07-10       Impact factor: 2.352

Review 2.  C-type lectin receptors in tuberculosis: what we know.

Authors:  Surabhi Goyal; Tilman E Klassert; Hortense Slevogt
Journal:  Med Microbiol Immunol       Date:  2016-07-28       Impact factor: 3.402

3.  Participation of the urokinase receptor in neutrophil efferocytosis.

Authors:  Young-Jun Park; Gang Liu; Yuko Tsuruta; Emmanuel Lorne; Edward Abraham
Journal:  Blood       Date:  2009-04-27       Impact factor: 22.113

4.  The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection.

Authors:  Jun Sato; Jeffrey Schorey; Victoria A Ploplis; Erijka Haalboom; Liana Krahule; Francis J Castellino
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

5.  Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment.

Authors:  Paulo Rabna; Andreas Andersen; Christian Wejse; Ines Oliveira; Victor Francisco Gomes; Maya Bonde Haaland; Peter Aaby; Jesper Eugen-Olsen
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

Review 6.  suPAR as a prognostic biomarker in sepsis.

Authors:  Katia Donadello; Sabino Scolletta; Cecilia Covajes; Jean-Louis Vincent
Journal:  BMC Med       Date:  2012-01-05       Impact factor: 8.775

7.  The blocking of uPAR suppresses lipopolysaccharide-induced inflammatory osteoclastogenesis and the resultant bone loss through attenuation of integrin β3/Akt pathway.

Authors:  Yosuke Kanno; Akira Ishisaki; Mei Miyashita; Osamu Matsuo
Journal:  Immun Inflamm Dis       Date:  2016-08-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.